Antonio Gasbarrini to Italy
This is a "connection" page, showing publications Antonio Gasbarrini has written about Italy.
Connection Strength
0.484
-
Real-life survey on severe asthma patients during COVID-19 lockdown in Italy. Expert Rev Respir Med. 2021 08; 15(8):1057-1060.
Score: 0.039
-
Predicting in-hospital mortality from Coronavirus Disease 2019: A simple validated app for clinical use. PLoS One. 2021; 16(1):e0245281.
Score: 0.039
-
Confirmed or unconfirmed cases of 2019 novel coronavirus pneumonia in Italian patients: a retrospective analysis of clinical features. BMC Infect Dis. 2020 Oct 19; 20(1):775.
Score: 0.038
-
The impact of SARS-CoV-2 pandemic on Oncologic and Degenerative Spine Surgery Department activity: the experience of Rizzoli Orthopaedic Institute under COVID-19 lockdown. Eur Rev Med Pharmacol Sci. 2020 07; 24(13):7519-7523.
Score: 0.037
-
Medicine in the time of Carracci: the cases of Domenico Lanzoni and Giuseppe Rosaccio. Eur Rev Med Pharmacol Sci. 2019 Jan; 23(2):464-470.
Score: 0.033
-
ACE I allele is associated with more severe portal hypertension in patients with liver cirrhosis: A pilot study. Dig Liver Dis. 2019 02; 51(2):293-296.
Score: 0.033
-
The healthcare service in Italy: regional variability. Eur Rev Med Pharmacol Sci. 2016 12; 20(1 Suppl):1-3.
Score: 0.029
-
Does chronic oral anticoagulation reduce in-hospital mortality among COVID-19 older patients? Aging Clin Exp Res. 2021 Aug; 33(8):2335-2343.
Score: 0.010
-
Donor program for fecal microbiota transplantation: A 3-year experience of a large-volume Italian stool bank. Dig Liver Dis. 2021 11; 53(11):1428-1432.
Score: 0.010
-
Clinical factors associated with death in 3044 COVID-19 patients managed in internal medicine wards in Italy: results from the SIMI-COVID-19 study of the Italian Society of Internal Medicine (SIMI). Intern Emerg Med. 2021 Jun; 16(4):1005-1015.
Score: 0.010
-
Predictors of in-hospital mortality AND death RISK STRATIFICATION among COVID-19 PATIENTS aged = 80 YEARs OLD. Arch Gerontol Geriatr. 2021 Jul-Aug; 95:104383.
Score: 0.010
-
Low seroprevalence of SARS-CoV-2 antibodies in cirrhotic patients. Dig Liver Dis. 2021 05; 53(5):541-544.
Score: 0.010
-
Predicting In-Hospital Mortality in COVID-19 Older Patients with Specifically Developed Scores. J Am Geriatr Soc. 2021 01; 69(1):37-43.
Score: 0.010
-
Surgical emergencies during SARS-CoV-2 pandemic lockdown: what happened? Eur Rev Med Pharmacol Sci. 2020 11; 24(22):11919-11925.
Score: 0.010
-
"Early transfusion of convalescent plasma in older patients with COVID-19 to prevent disease progression: A structured summary of a study protocol for a randomised controlled trial". Trials. 2020 Oct 22; 21(1):875.
Score: 0.009
-
Mental health and counseling intervention for hereditary hemorrhagic telangiectasia (HHT) during the COVID-19 pandemic: perspectives from Italy. Eur Rev Med Pharmacol Sci. 2020 Oct; 24(19):10225-10227.
Score: 0.009
-
Maintaining standard volumes, efficacy and safety, of fecal microbiota transplantation for C. difficile infection during the COVID-19 pandemic: A prospective cohort study. Dig Liver Dis. 2020 12; 52(12):1390-1395.
Score: 0.009
-
Predicting intensive care unit admission and death for COVID-19 patients in the emergency department using early warning scores. Resuscitation. 2020 11; 156:84-91.
Score: 0.009
-
Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centre. United European Gastroenterol J. 2020 08; 8(7):775-781.
Score: 0.009
-
The concept of therapeutic hierarchy for patients with hepatocellular carcinoma: A multicenter cohort study. Liver Int. 2019 08; 39(8):1478-1489.
Score: 0.009
-
Impact evaluation of a Critical Pathway for patients with Clostridium difficile infection: A pre-post analysis in a Third Level Referral Center. Int J Infect Dis. 2019 Mar; 80:105-110.
Score: 0.008
-
Real life experiences in HCV management in 2018. Expert Rev Anti Infect Ther. 2019 02; 17(2):117-128.
Score: 0.008
-
Acute HEV hepatitis: clinical and laboratory diagnosis. Eur Rev Med Pharmacol Sci. 2019 Jan; 23(2):764-770.
Score: 0.008
-
Hepatic encephalopathy 2018: A clinical practice guideline by the Italian Association for the Study of the Liver (AISF). Dig Liver Dis. 2019 02; 51(2):190-205.
Score: 0.008
-
Restaging Patients With Hepatocellular Carcinoma Before Additional Treatment Decisions: A Multicenter Cohort Study. Hepatology. 2018 10; 68(4):1232-1244.
Score: 0.008
-
May nutritional status worsen during hospital stay? A sub-group analysis from a cross-sectional study. Intern Emerg Med. 2019 Jan; 14(1):51-57.
Score: 0.008
-
Forecasting Hepatitis C liver disease burden on real-life data. Does the hidden iceberg matter to reach the elimination goals? Liver Int. 2018 12; 38(12):2190-2198.
Score: 0.008
-
The use of single balloon enteroscopy in Crohn's disease and its impact on clinical outcome. Scand J Gastroenterol. 2018 Aug; 53(8):925-929.
Score: 0.008
-
Metabolic disorders across hepatocellular carcinoma in Italy. Liver Int. 2018 11; 38(11):2028-2039.
Score: 0.008
-
Risk, prevalence, and impact of hospital malnutrition in a Tertiary Care Referral University Hospital: a cross-sectional study. Intern Emerg Med. 2018 08; 13(5):689-697.
Score: 0.008
-
The ten commandments of hepatic radioembolization: expert discussion and report from Mediterranean Interventional Oncology (MIOLive) congress 2017. Eur Rev Med Pharmacol Sci. 2017 Sep; 21(18):4014-4021.
Score: 0.008
-
Sustainability of Endovenous Iron Deficiency Anaemia Treatment: Hospital-Based Health Technology Assessment in IBD Patients. Biomed Res Int. 2017; 2017:3470893.
Score: 0.008
-
XRCC1 Arg399Gln gene polymorphism and hepatocellular carcinoma risk in the Italian population. Int J Biol Markers. 2017 May 04; 32(2):e190-e194.
Score: 0.007
-
May Gender or Ethnicity Affect Delta Over Baseline Values Obtained by 13-C Urea Breath Test? Rev Recent Clin Trials. 2017; 12(3):187-192.
Score: 0.007